Dr. Medha Satyarengga, MD

Dr. Satyarengga practices at University of Maryland Shore Medical Center at Easton in Easton, Maryland, part of University of Maryland Medical System.

Dr. Satyarengga's NPI, 1538574314, was assigned on June 30, 2014. Dr. Satyarengga holds Maryland license D87509.

Dr. Satyarengga's primary practice is University of Maryland Shore Medical Center at Easton, at 219 South Washington Street, Easton, MD 21601 in Talbot County. The practice phone is (410) 822-1000.

Dr. Satyarengga's primary practice is University of Maryland Shore Medical Center at Easton in Easton, Maryland, part of University of Maryland Medical System. Dr. Satyarengga is also affiliated with TidalHealth Peninsula Regional. The medical group on file is UM Community Medical Group. Dmand AI also links Dr. Satyarengga to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Satyarengga practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Satyarengga's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Satyarengga is licensed in Maryland.

CMS data shows 3,203 Medicare services from Dr. Satyarengga across 12 procedure codes in 2024, for 960 Medicare patients. Medicare paid $144,632 for them.

CMS counts 960 Medicare patients who saw Dr. Satyarengga in 2024. The largest group is 65 to 74, with 444 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Satyarengga's median patient age at 70, with 69% women.

In 2024, Dr. Satyarengga wrote 6,418 Medicare Part D claims for 954 patients. 41% of them were for generic drugs. CMS names the drug for 5,966 of them, across 78 drugs with 11 or more claims each, at $2,568,973 in total drug cost. In 2023, CMS named 5,003 claims across 73 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Satyarengga for performance year 2024, reported as part of a group. Dr. Satyarengga accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Satyarengga as offering telehealth.

CMS Open Payments shows 342 general payments to Dr. Satyarengga from 32 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 90% of the total. Novo Nordisk Inc paid the most, $1,120.